SCHEMBL22375313

SCHEMBL22375313

CCCCCCC(C)(CCCC)c1cccnc1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 1/20 0.37
SLC22A12 Q96S37 1/20 0.36
NFE2L2 Q16236 2/20 0.36
TLR8 Q9NR97 3/20 0.35
SLC13A5 Q86YT5 1/20 0.34
APLNR P35414 1/20 0.34
CNR1 P21554 5/20 0.34
CNR2 P34972 5/20 0.34
TLR7 Q9NYK1 2/20 0.33
TSHR P16473 2/20 0.33
USP2 O75604 2/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
MEN1 O00255 1/20 0.33
GLA P06280 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22375253 0.99 P2RY1 (0.37) P2RY1SLC22A12NFE2L2TLR8SLC13A5
SCHEMBL22624032 0.96 P2RY1 (0.39) P2RY1SLC22A12NFE2L2TLR8SLC13A5
SCHEMBL21970992 0.80 SLC22A12 (0.42) P2RY1SLC22A12NFE2L2SLC13A5APLNR
SCHEMBL21191754 0.79 TLR8 (0.36) P2RY1TLR8CNR1CNR2TLR7
SCHEMBL21191599 0.78 TLR8 (0.35) P2RY1TLR8CNR1CNR2TLR7
SCHEMBL21191591 0.76 TLR8 (0.36) P2RY1TLR8CNR1CNR2TLR7
SCHEMBL25101222 0.75 TSHR (0.44) TLR8TLR7TSHRLMNACYP2D6
SCHEMBL23419175 0.74 SSTR4 (0.39) TLR8CNR1CNR2TLR7TSHR
SCHEMBL25101234 0.74 TLR8 (0.40) TLR8TLR7TSHRLMNAMEN1
SCHEMBL20313081 0.74 CNR2 (0.49) CNR1CNR2TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10959432-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2021-03-30 US disclosed
US-20200267986-A1 Microbiocidal Oxadiazole Derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10959432-B2 Microbiocidal oxadiazole derivatives PRF1, NOX1, ARG1 P2RY1 1221/4885SLC22A12 3208/4885NFE2L2 1776/4885
US-20200267986-A1 Microbiocidal Oxadiazole Derivatives PRF1, NOX1, ARG1 P2RY1 1221/4885SLC22A12 3208/4885NFE2L2 1776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.